Abstract
A total of 116 hospitalized patients between May 2006 and March 2012 were divided into observation (n=39), treatment control (n=41) and blank control group (n=36). All groups received standard doses of chemotherapy with 5-fluorouracil. Patients in observation group received a daily intravenous infusion of 100 mg magnesium isoglycyrrhizinate plus chemotherapy while those in the treatment control group a daily 1.2 g reduced glutathione intravenous infusion plus chemotherapy. And the blank control group accepted chemotherapy alone. The parameters of liver function, including aspartate aminotransferase, alkaline phosphatase, gamma glutamyl transferase, lactate dehydrogenase, total bilirubin and albumin, were recorded and compared at Week 1. No significantly difference in the above parameters was found in observation group (P>0.05). However, in treatment control and blank control groups, significant statistical differences existed in some of the parameters (P<0.05). Magnesium Isoglycyrrhizinate is an efficient protector of liver function for patients on chemotherapy with 5-fluorouracil. Key words: Glycyrrhizic acid; Antineoplastic combined chemotherapy protocols
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
